Kornitzer Capital Management Inc Biomarin Pharmaceutical Inc Transaction History
Kornitzer Capital Management Inc
- $4.65 Billion
- Q1 2025
A detailed history of Kornitzer Capital Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 10,270 shares of BMRN stock, worth $637,356. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,270
Previous 7,970
28.86%
Holding current value
$637,356
Previous $523,000
38.62%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
648Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.18 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.1 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$915 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$806 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...